Loading…
Seer, Inc. is projected to rise to $2.56 by 2027, a +15% move from its current price of $2.22. SEER is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/3/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 4 | $2.16 | $2.22 | $2.29 | +0.08% |
| Aug 5 | $2.13 | $2.22 | $2.32 | +0.17% |
| Aug 6 | $2.11 | $2.23 | $2.34 | +0.25% |
| Aug 7 | $2.10 | $2.23 | $2.36 | +0.33% |
| Aug 8 | $2.09 | $2.23 | $2.38 | +0.42% |
| Aug 9 | $2.08 | $2.23 | $2.40 | +0.50% |
| Aug 10 | $2.06 | $2.23 | $2.41 | +0.58% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $2.06 | $2.23 | $2.41 | +0.58% |
| Week 2 | $2.01 | $2.25 | $2.51 | +1.17% |
| Week 3 | $1.97 | $2.26 | $2.59 | +1.76% |
| Week 4 | $1.94 | $2.27 | $2.66 | +2.35% |
| Week 5 | $1.92 | $2.29 | $2.72 | +2.95% |
| Week 6 | $1.90 | $2.30 | $2.79 | +3.55% |
| Week 7 | $1.88 | $2.31 | $2.84 | +4.15% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Seer, Inc. is a life sciences company focused on decoding the biology of the proteome to improve human health. It develops and commercializes products that enable proteomic analysis, including the Proteograph Product Suite and related offerings, designed for research use only and usable by laboratories worldwide.
The company markets engineered solutions, automation, and data analytics tools to support proteomic research in academic, biopharma, and biotechnology settings.
Seer was incorporated in 2017 and is headquartered in Redwood City, California. It was formerly known as Seer Biosciences, Inc. and changed its name to Seer, Inc. in July 2018. The description below reflects Seer’s ongoing business scope and geographic reach across the United States, China, Australia, Europe, Israel, Japan, and South Africa.
Seer operates in the life sciences sector with products that are intended for non-diagnostic and non-clinical research use. The Proteograph Product Suite includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis software to perform proteomic analysis. Other offerings include Proteograph ONE, Proteograph DIRECT, and Proteograph Analysis Suite, a cloud-based data analytics platform for quality control, data management, and interpretation of proteograph output.
Seer, Inc. (SEER) is a life sciences company with a current price of $2.14 and a market capitalization of $108.31M, ranking 5445 by market cap. The near-term outlook aligns with a neutral price path in the initial forecast window, while longer horizons show meaningful upside as the price forecast progresses.
In 2026, the avg price is $2.14 with a min of $1.62 and a max of $2.97, indicating a flat-to-broadly-range start. From 2027 onward, the forecast depicts a gradual ascent, with 2027 at $2.40, 2028 at $2.55, and 2029 at $2.77 on average. The multi-year trajectory accelerates later, with 2030 at $2.96, 2040 at $6.74, and 2050 at $12.42 on average, while max values reach $4.15, $10.75, and $21.45 respectively, and ROIs expand to 38.3%, 214.7%, and 480.1%.
A major floor 36.0% below — a decisive break under it would weaken the trend.
The nearest floor, 27.0% below — buyers have tended to step in here.
Price is pressing into resistance (0.0% away) — a breakout level to watch.
A major ceiling 18.0% above — clearing it would confirm fresh momentum.
Key SEER support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of SEER market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $2.09 | Buy | $2.12 | Buy |
| MA 10 | $2.07 | Buy | $2.09 | Buy |
| MA 20 | $2.12 | Buy | $2.05 | Buy |
| MA 50 | $1.90 | Buy | $1.96 | Buy |
| MA 100 | $1.86 | Buy | $1.91 | Buy |
| MA 200 | $1.91 | Buy | $1.93 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 63.04 | Neutral |
| Stoch RSI (14) | 66.95 | Neutral |
| CCI (20) | 98.16 | Neutral |
| Williams %R (14) | 0.00 | Info |
| MACD (12,26,9) | -0.00 | Sell |
| ROC (12) | 2.78 | Buy |
| Bollinger %B (20,2) | 0.82 | Neutral |
| Stochastic %K (14) | 100.00 | Sell |
| TRIX (15) | 0.53 | Buy |
| Awesome (5,34) | 0.15 | Buy |
| Ultimate (7,14,28) | 61.34 | Neutral |
| Momentum (10) | 0.05 | Buy |
| Aroon Osc (25) | 80.00 | Buy |
| Hull MA (9) | 2.13 | Buy |
| ADX (14) | 22.13 | Buy |
| ATR (14) | 0.06 | Info |
The 30-day technical picture is NEUTRAL with an RSI of 50. The short-term moving averages sit around the current level, with the SMA50 at $1.87 and the SMA200 at $1.91. Support is identified at $1.62, while resistance sits at $2.22.
The 30-day price range runs from a low of $1.84 to a high of $2.48, illustrating a near-term trading band around the current price.
Annualized volatility stands at 40%, underscoring notable near-term price swings within the wider range.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.62 | $2.22 | $3.22 | 0% | Neutral | |
| $2.02 | $2.56 | $3.42 | +15% | Neutral | |
| $2.09 | $2.73 | $3.80 | +23% | Bullish | |
| $2.25 | $3.00 | $4.32 | +35% | Bullish | |
| $2.43 | $3.33 | $4.91 | +50% | Bullish | |
| $2.97 | $4.14 | $6.26 | +87% | Bullish | |
| $3.28 | $4.67 | $7.20 | +110% | Bullish | |
| $3.49 | $5.06 | $7.95 | +128% | Bullish | |
| $3.63 | $5.34 | $8.54 | +141% | Bullish | |
| $3.55 | $5.32 | $8.64 | +140% | Bullish | |
| $5.17 | $8.35 | $14.47 | +276% | Bullish | |
| $8.70 | $16.00 | $30.48 | +621% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $1.62 | $2.22 | $2.78 | +0.00% |
| September 2026 | $2.02 | $2.40 | $2.92 | +7.89% |
| October 2026 | $2.01 | $2.39 | $2.96 | -0.02% |
| November 2026 | $2.03 | $2.45 | $3.05 | +2.11% |
| December 2026 | $2.12 | $2.56 | $3.22 | +4.74% |
Click any year to see its month-by-month SEER forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Seer, Inc.'s 2026 outlook centres on $2.22, within a $1.62 to $3.22 range. That marks a 0% change versus current levels. Price action looks broadly range-bound.
By 2027, SEER could reach as high as $3.42, with a base case around $2.56 and support toward $2.02 — roughly +15% from $2.22. A consolidation phase looks the most probable path here.
Expect SEER to range from $2.09 to $3.80 through 2028. The $2.73 average target implies a +23% move from current prices. That is up +7% on the projected 2027 average. Momentum favours further upside here.
The SEER price prediction for 2029 points to an average of $3.00 (low $2.25, high $4.32) — a potential gain of +35% on today's $2.22. Buyers look set to stay in control over this stretch.
In 2030, SEER is projected to trade between $2.43 and $4.91, averaging $3.33 — a potential gain of +50% from today's $2.22. That is up +11% on the projected 2029 average. Momentum favours further upside here.
Seer, Inc.'s 2031 outlook centres on $4.14, within a $2.97 to $6.26 range. That is up +24% on the projected 2030 average. That marks a +87% change versus current levels. Buyers look set to stay in control over this stretch.
By 2032, SEER could reach as high as $7.20, with a base case around $4.67 and support toward $3.28 — roughly +110% from $2.22. Momentum favours further upside here.
Expect SEER to range from $3.49 to $7.95 through 2033. The $5.06 average target implies a +128% move from current prices. That is up +8% on the projected 2032 average. Buyers look set to stay in control over this stretch.
The SEER price prediction for 2034 points to an average of $5.34 (low $3.63, high $8.54) — a potential gain of +141% on today's $2.22. Momentum favours further upside here.
In 2035, SEER is projected to trade between $3.55 and $8.64, averaging $5.32 — a potential gain of +140% from today's $2.22. That is 0% versus the projected 2034 average. Buyers look set to stay in control over this stretch.
Seer, Inc.'s 2040 outlook centres on $8.35, within a $5.17 to $14.47 range. That is up +57% on the projected 2035 average. That marks a +276% change versus current levels. Momentum favours further upside here.
By 2050, SEER could reach as high as $30.48, with a base case around $16.00 and support toward $8.70 — roughly +621% from $2.22. Buyers look set to stay in control over this stretch.
Investing $1,000 in SEER today (≈ 450.45045 SEER) could be worth
$7,206.07
+$6,206.07 (+621%) by 2050 · US Dollar
Based on the average projected SEER price of $16 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in SEERwould be worth at today's price.
$1,000 invested in SEER on Jul 31, 2025 (≈ 471.698139 SEER) would be worth
$1,047.17
+$47.17 (+4.7%) today · 1.05× · US Dollar
Based on a SEER entry price of $2.12 vs. today's $2.22.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $1.97 | $1,126.9 | +12.7% |
| 1 month ago | $1.63 | $1,361.96 | +36.2% |
| 3 months ago | $2.03 | $1,093.6 | +9.4% |
| 6 months ago | $1.81 | $1,226.52 | +22.7% |
| 1 year ago | $2.12 | $1,047.17 | +4.7% |
| All time (5.0y) ago | $31.45 | $70.59 | -92.9% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our SEER forecast.
Our base-case forecast reaches $4.40 around 2032.
Implied market cap at $4.40: $241.92M
The multi-year forecast shows an ongoing uptrend beginning in 2029, with 2029 at an avg of $2.77 and a max of $3.80, yielding an ROI of 29.3% and a bullish sentiment. The upward arc continues in 2030, where the avg is $2.96, the max $4.15, and the ROI is 38.3%, supported by a bullish stance.
Looking further ahead, 2040 is characterized by strong upside, with an avg of $6.74, a max of $10.75, and a 214.7% ROI. By 2050, the forecast shows an avg of $12.42, a max of $21.45, and a landmark ROI of 480.1% in a bullish scenario. These figures reflect a sustained positive trajectory across decades, though they are estimates and not guarantees.
Tap a question to reveal the answer.
In 2030 the forecast shows min $2.26, avg $2.96, max $4.15, with ROI 38.3% and sentiment BULLISH.
The forecast presents a path of rising average price through 2029-2050, with an avg price reaching $12.42 by 2050, max $21.45, and ROI up to 480.1%, though these are estimates and not guarantees.
Yes—by 2040 the max is $10.75, and by 2050 the max is $21.45, indicating the potential to exceed $10 under the forecast.
Current price is $2.14 and market cap is $108.31M.
The 30-day range is $1.84 to $2.48, with current price around $2.14 and a neutral near-term sentiment.
Seer, Inc. Community Discussion
0Share your Seer, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.